Poor concordance between FGFR1 amplification, as determined by fluorescence in situ hybridization (FISH), and FGFR1 mRNA overexpression, as determined by RNAscope, has recently been reported in > 20% of HR+BC patients3. Here, FGFR1 is linked to breast cancer.